Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer
2023 · Journal of Experimental & Clinical Cancer Research · 21 citations
https://doi.org/10.1186/s13046-023-02606-3